The DOI matches its Crossref record.
A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of Atherosclerosis
Abstract
This report describes a clinical trial, with domiciled male veterans, designed to determine whether a diet which lowers serum cholesterol concentration can prevent overt complications of coronary heart disease and other manifestations of atherosclerosis. Volunteers were allocated randomly to control and experimental groups. Participants numbered 422 in the control group and 424 in the experimental group. The two groups were indistinguishable at the outset of the study in almost all observations. These included age, racial characteristics, and religious affiliation; height, weight, and blood pressure; electrocardiographic findings; prevalence of pre-existing anginal syndrome, myocardial infarction, peripheral atherosclerosis, cerebral ischemia, or cerebral infarction; cardiac decompensation; utilization of relevant medications; serum cholesterol and serum total lipid levels; and prevalence of corneal arcus and xanthelasma. One significant difference between the groups in regard to a possibly influential characteristic was that they differed slightly in patterns of cigarette smoking habits. The control diet was similar to the regular institutional diet, which is a standard American diet. It provided, by analysis, 40.1% of calories as fat, having a mean iodine value of 53.5; cholesterol intake was 262 mg/1,000 calories (653 mg/day). The experimental diet provided 38.9% of calories as fat, with an iodine value of 102.4, and had a cholesterol content of 146 mg/1,000 calories (365…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Five studies were conducted in European countries (15), (18), (19), (21), (23), 2 in the USA (20), (22), 1 in Australia (24), and 1 in India (25).”
From Saturated Fat Restriction for Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials (2025) · cites this paper as [20]
In the citing paper
“Only 2 studies were primary prevention trials from the USA (20), (22); the remaining 7 were secondary prevention trials.”
From Saturated Fat Restriction for Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials (2025) · cites this paper as [20]
In the citing paper
“Only 3 studies were on stroke (20), (23), (25), and the incidence of stroke was almost zero in 2 of those studies (23), (25).”
From Saturated Fat Restriction for Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials (2025) · cites this paper as [20]
In the citing paper
“Although we did not observe statistically significant CVD prevention due to SFA reduction, several studies included in our meta-analysis reported positive results with SFA reduction (15), (19), (20), (23).”
From Saturated Fat Restriction for Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials (2025) · cites this paper as [20]
In the citing paper
“Furthermore, in previous studies showing positive outcomes (15), (19), (20), (23), statins were not prescribed to the participants.”
From Saturated Fat Restriction for Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials (2025) · cites this paper as [20]
In the citing paper
“Specifically, each 1-mmol/L reduction in LDL-C was associated with an RR of 0.75 (95% CI, 0.66-0.86;P = .002)in major vascular events”
From Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis (2016) · cites this paper as [49]
Citations
Cited by
Sorted by citations
Items 401–500 of 543
Modification of the diet in primary prevention trials
Karvonen, M. (1972) · Proceedings of the Nutrition Society · doi:10.1079/pns19720063 · Cited by 4
Deurenberg-Yap, M. (2000) · doi:10.18174/197425 · Cited by 4
Elevated Serum Cholesterol in Asymptomatic Adults
Woolf, S. (1990) · doi:10.1007/978-1-4612-3280-3_40 · Cited by 4
Dietary Fat and Coronary Heart Disease: Evidence of a Causal Relation
Kushi, L., & Kottke, T. (1990) · doi:10.1007/978-1-4612-3280-3_39 · Cited by 4
Henry, P. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90328-2 · Cited by 4
Coronary risk factors and mortality for coronary and non-coronary events
Menotti, A. (1982) · doi:10.1007/978-94-009-7331-2_34 · Cited by 4
Planning the type II coronary primary prevention trial of the lipid research clinics (U. S. A.).
Steinberg, D. (1975) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4684-3258-9_33 · Cited by 4
Adipose tissue fatty acid differences in American men between 1962 and 1966.
Insull, W., Lang, P., & Hsi, B. (1970) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/23.1.17 · Cited by 4
Sun, Q., & Hu, F. B. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101669 · Cited by 3
Metabolic Medicine and Surgery
Rothkopf, M. M., Nusbaum, M. J., & RDN, C. (2014) · CRC Press eBooks · doi:10.1201/b17616 · Cited by 12
Don't disregard the essential distinction between PUFA species
Ramsden, C. E., Hibbeln, J. R., Majchrzak‐Hong, S. F., & Davis, J. M. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511001061 · Cited by 3
Lowering Cholesterol in Old Age
Oliver, M. (1999) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)01721-0 · Cited by 3
Dietary polyunsaturated fatty acids and aortic plaques
Crawford, M., Leaf, A., Truswell, A., Felton, C., Crook, D., Davies, M. J., & Oliver, M. (1995) · doi:10.1016/s0140-6736(95)90253-8 · Cited by 3
Imagine no coronary heart disease.
Kaplan, R. M. (1991) · Circulation · doi:10.1161/01.cir.83.4.1452 · Cited by 3
Hornstra, G. (1988) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002756 · Cited by 3
Sudden coronary death: approaches to its prevention.
Stamler, J. (1976) · The Medical clinics of North America · doi:10.1016/s0025-7125(16)31908-3 · Cited by 3
The Effect of Sodium Dextrothyroxine On Serum Cholesterol and Mortality Rates in Cardiac Patients
Bernstein, A., Simon, F., Schmitz, T. H., & Warner, W. (1973) · Angiology · doi:10.1177/000331977302400402 · Cited by 3
Low-Carbohydrate Diets in the Treatment of the Metabolic Syndrome
Cornier, M., & Draznin, B. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1331-8_7 · Cited by 2
Dietary Macronutrients and Cardiovascular Risk
Kris-Etherton, P., Hecker, K. D., Taylor, D. S., Zhao, G.-X., Coval, S., & Binkoski, A. (2001) · Elsevier eBooks · doi:10.1016/b978-012193155-1/50020-9 · Cited by 3
Lipid effects of antihypertensive drugs.
Leren, P. (1990) · Clinical and Experimental Hypertension Part A Theory and Practice · doi:10.3109/10641969009073497 · Cited by 3
Preventive cardiology: a progress report.
Pyörälä, K. (1990) · Preventive Medicine · doi:10.1016/0091-7435(90)90011-8 · Cited by 3
Applications of Behavioral Medicine with Children I. Epidemiology of Coronary Heart Disease
Cinciripini, P. M. (1984) · Progress in behavior modification · doi:10.1016/b978-0-12-535617-6.50007-x · Cited by 3
Compliance and Cholestorol-Lowering in Clinical Trials: Efficacy of Diet
Rifkind, B., Goor, R., & Schucker, B. (1983) · doi:10.1007/978-3-642-81817-2_59 · Cited by 3
Dietary Prevention of Coronary Heart Disease: The Role of Essential Fatty Acids
Oliver, M. (1980) · doi:10.1007/978-1-4612-6071-4_46 · Cited by 3
Prospects with multifactorial approaches emphasizing improvement in life style.
Stamler, J., & Berkson, D. (1972) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4684-7547-0_19 · Cited by 3
(2025) · JMA Journal · doi:10.31662/jmaj.2024-0324 · Cited by 2
“Only 3 studies were on stroke (20), (23), (25) , and the incidence of stroke was almost zero in 2 of those studies (23), (25) .”
InfluentialCaterina, R. D., Salvatore, T., & Marchioli, R. (2016) · Data in Brief · doi:10.1016/j.dib.2016.04.059 · Cited by 2
Dietary Fats and Heart Disease: From Prenatal to Postnatal Environment
B. (2012) · Current Research in Medicine · doi:10.3844/amjsp.2012.175.182 · Cited by 1
Further response from Hoenselaar
Hoenselaar, R. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000402 · Cited by 5
“In addition, subgroup analyses within the trials show that changes in cholesterol did not always correspond to predicted effects on CHD((14,20,21)).”
BackgroundReview: effects of dietary fatty acids and fibers on blood cholesterol.
Ghatak, A., Monte, G., Garcia, M., & Tsushima, M. (1992) · Japanese Journal of Medical Science & Biology · doi:10.7883/yoken1952.45.99 · Cited by 2
Prevention and regression of atherosclerosis with drug therapy
Superko, H. R. (1991) · Clinical Cardiology · doi:10.1002/clc.4960141307 · Cited by 2
Diet and coronary heart disease: The challenge before us
Kris-Etherton, P., Dreon, D., & Wood, P. (1987) · doi:10.1016/s0022-3182(87)80052-3 · Cited by 2
Modifications in food intake by myocardial infarct patients.
Kris-Etherton, P., Miller, R., Remick, B. A., & Wilkinson, W. (1983) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)07759-2 · Cited by 2
Yatsu, F. (1981) · Neurology · doi:10.1212/wnl.31.12.1535 · Cited by 2
Prevention of cardiovascular disease
Kannel, W. B. (1976) · Current Problems in Cardiology · doi:10.1016/s0146-2806(76)80002-3 · Cited by 4
Clinical and metabolic characteristics. Effects on mortality in coronary disease.
Reynertson, R., & Tzagournis, M. (1973) · Archives of Internal Medicine · doi:10.1001/archinte.1973.03650110011003 · Cited by 2
A study of the primary prevention of coronary heart disease.
Keller, M. D., Anthony, J. R., & Gresham, G. E. (1970) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.60.8.1466 · Cited by 2
Mediterranean Diet and Lifestyle in a Modern World Context
Romagnolo, D., & Selmin, O. (2016) · doi:10.1007/978-3-319-27969-5_2 · Cited by 2
“cardiovascular diseases [ 44 , 45 ].”
Primary Prevention of Ischemic Heart Disease
Meadows, J. L., Danik, J. S., & Albert, M. A. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3358-5.50015-2 · Cited by 4
Cholesterol management in general practice.
White, H. L., & Roberts, D. (1997) · Current Medical Research and Opinion · doi:10.1185/03007999709113343 · Cited by 2
Is there an association among low untreated serum lipid levels, anger, and hazardous driving?
Davidson, K., Reddy, S., McGrath, P. J., & Zitner, D. (1996) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm0304_3 · Cited by 2
Total mortality in cardiovascular risk factor intervention trials.
Faergeman, O. (1990) · Scandinavian journal of clinical and laboratory investigation. Supplementum · doi:10.1080/00365519009090535 · Cited by 2
Dietary Fatty Acids and Platelet Composition and Function in Human Studies
Renaud, S. (1987) · doi:10.1007/978-1-4615-9495-6_9 · Cited by 2
Epidemiologie der Risikofaktoren
Nüssel, E., Buchholz, L., & Morgenstern, W. (1984) · Springer eBooks · doi:10.1007/978-3-642-69451-6_5 · Cited by 2
Cholesterol and Atherosclerosis
Myant, N. (1981) · Elsevier eBooks · doi:10.1016/b978-0-433-22880-6.50020-5 · Cited by 2
Management of the hyperlipidaemias.
Jowett, N., & Galton, D. (1980) · Drug and therapeutics bulletin · doi:10.1007/978-1-4899-3294-5_12 · Cited by 2
The Rationale for Hypolipemic Therapy
Frantz, I. (1975) · doi:10.1007/978-3-642-66190-7_10 · Cited by 2
Huang, N. K., Lichtenstein, A. H., Matuszek, G., & Matthan, N. R. (2023) · Metabolites · doi:10.3390/metabo13040474 · Cited by 1
Evolution of the Lipid Clinic, 1968–2008
Lewis, B. (2011) · doi:10.1002/9781444318456.ch32 · Cited by 1
Park, J., Oh, S., Kim, K., Ahn, S.-H., & Kim, Y. K. (1999) · doi:10.4070/kcj.1999.29.3.266 · Cited by 1
LDL-cholesterol lowering and atherosclerosis - clinical benefit and possible mechanisms: an update
Kroon, A. A., & Stalenhoef, A. F. H. (1997) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(97)00031-4 · Cited by 1
The long-term safety of antihyperlipidaemic drugs
Ødegaard, O. (1991) · International Journal of Risk and Safety in Medicine · doi:10.3233/jrs-1991-2404 · Cited by 1
“The beneficial effect of intervention in the form of advice on diet and smoking in preventing coronary heart disease has been demonstrated in several studies [1-3].”
Surely a natural cancer remedy can't be dangerous.
Bury, B. (1990) · British medical journal · doi:10.1136/bmj.301.6755.814 · Cited by 1
Lowering cholesterol concentrations and mortality
Ravnskov, U. (1990) · doi:10.1136/bmj.301.6755.814-b · Cited by 1
Health education, health promotion or drugs? Cholesterol and coronary heart disease
Wilson, A., Leeder, S., & Isacsson, S. (1990) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1990.tb125381.x · Cited by 1
Managing Elevated Blood Lipid Concentrations
Dart, A. M. (1990) · Drugs · doi:10.2165/00003495-199039030-00004 · Cited by 13
Diet and Coronary Heart Disease
Sanders, T. (1987) · Journal of the Royal Society of Health · doi:10.1177/146642408710700502 · Cited by 1
慢性期脳梗塞患者における血漿, 赤血球, 血小板脂肪酸組成の異常動脈硬化ならびに血小板凝集能との関連において
藤本, 直., 宮原, 忠., 村井, 淳., 塩, 栄., & 亀山, 正. (1987) · doi:10.3995/jstroke.9.78 · Cited by 1
Lesko, R. M., & Abbey, D. E. (1987) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1987-870117 · Cited by 1
Miller, G. (1984) · doi:10.1177/014107688407701123 · Cited by 1
“Only in the Los Angeles Veterans Trial of diet and CHD was an excess of gastric cancer observed in those with a diet of relatively high P/S ratio (Dayton et al. 1969), and even here the association was lost on later follow up.”
BackgroundTechnical Notes: The Nursing Clinical Trial
Tyzenhouse, P. (1981) · doi:10.1177/019394598100300123 · Cited by 1
Diet in the treatment of hyperlipidemia.
Spritz, N. (1980) · American Heart Journal · doi:10.1016/0002-8703(80)90075-7 · Cited by 1
DIETARY FAT AND CORONARY HEART DISEASE: A REVIEW*: III. A COMMUNITY PROGRAMME
(1974) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1974.tb93234.x · Cited by 1
Nutrition and cardiovascular disease.
Schattenberg, T. T., & Brandenburg, R. O. (1970) · The Medical clinics of North America · doi:10.1016/s0025-7125(16)32564-0 · Cited by 1
Effects of polyunsaturated fatty acid–rich diets and risk of non-communicable diseases
Singh, R. B., Watanabe, S., Li, D., Nakamura, T., Juneja, L. R., Takahashi, T., Wichansawakun, S., Wilczyńska, A., Jantan, I., Sulaeman, A., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819815-5.00011-2 · Cited by 7
Han, K., Willams, K. J., & Goldberg, A. C. (2021) · Contemporary cardiology · doi:10.1007/978-3-030-78177-4_7 · Cited by 3
What caused the obesity epidemic?
Harcombe, Z. (2015) · Trends in Urology & Men s Health · doi:10.1002/tre.436 · Cited by 1
Nutrition and cardiovascular disease
Martínez-González, M., Bes-Rastrollo, M., & Press, C. (2014) · doi:10.1201/b17616-10 · Cited by 1
Lipid Lowering Drugs and Coronary Heart Disease
Scott, P. (2012) · Drugs · doi:10.2165/00003495-197510030-00004 · Cited by 1
Maisch, B., Steliwaag, M., & Simon, B. C. (1994) · Zusammenarbeit von Klinik und klinischer Chemie · doi:10.1007/978-3-642-52362-5_6
The Brisighella study: plasma lipid trend in the elderly observed over a twelve year period
Descovich, G., Ceredi, C., de Simone, G., Dormi, A., Magri, G., Minardi, A., Santarella, M., Sisca, G., Sangiorgi, Z., Vigna, M., et al. (1990) · doi:10.1007/978-94-009-0731-7_6 · Cited by 1
The Significance of Dietary Fat for Metabolic Diseases and Atherosclerosis in Particular
Menotti, A., & Seccareccia, F. (1987) · doi:10.1007/978-1-4615-9495-6_3 · Cited by 1
Cummings, N. B., & Klahr, S. (1985) · Springer US · doi:10.1007/978-1-4684-4826-9 · Cited by 1
“8954 (15) 3148 (31) 16045 (20) 24833 (15) Transplant (x)”
BackgroundDietary Components and the Risk of Coronary Heart Disease Mortality
Kromhout, D. (1985) · Springer eBooks · doi:10.1007/978-1-4684-7929-4_8 · Cited by 1
The good and bad of lowering serum cholesterol
Oliver, M. (1982) · doi:10.1007/978-94-009-7331-2_15 · Cited by 1
Cholesterol and coronary disease —Outstanding questions
Oliver, M. F. (2004) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00054559
Dietary Patterns for the Prevention and Treatment of Cardiovascular Disease
Kris‐Etherton, P. M., Ohlson, M., Bagshaw, D., & Stone, N. J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50023-8 · Cited by 5
Oils and Fats in the Prevention and Treatment of Cardiovascular Disease
Kris‐Etherton, P. M., Hecker, K. D., Etherton, T. D., & Fishell, V. K. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-728-4_6 · Cited by 1
虚血性潰瘍の治癒後に継続する足部のシビレ·冷感·安静時疼痛に対して, γリノレン酸が有効であった閉塞性動脈硬化症の1例
飯島, 茂., 津田, 毅., 並川, 健., & 鈴木, 靖. (2003) · doi:10.2336/nishinihonhifu.65.483
Risk factors for non-haemorrhagic stroke and the effect of lipid-modifying therapy
Jackson, P. R. (2002) · Journal of Hypertension · doi:10.1097/00004872-200212000-00013
Guthrie, C. I. (2001) · British medical journal · doi:10.1136/bmj.323.7319.997
Oliver, M. (1996) · ACC Current Journal Review · doi:10.1016/1062-1458(96)00053-0
State-of-the-Art Review : Sex and Cardiovascular Risk Factors
Prisco, D., Caciolli, S., Pace, S. D., & Gensini, G. F. (1996) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602969600200203
“One point for discussion is the fact that, although the body of evidence from primary and secondary prevention trials of cholesterol reduction clearly demonstrates decreases in deaths from CHD, total mortality has not been reduced (37-44).”
The Effect of Low-Fat Diet on Lipid Levels-Reply
Schaefer, E. J. (1996) · JAMA · doi:10.1001/jama.1996.03530340023023
Mood Disorders and Cholesterol-Lowering Drugs
Strandberg, T., & Tilvis, R. (1995) · doi:10.2165/00023210-199503060-00001
Joseph, A., Talley, J. D., Shih, A., Crum, T., Vogel, R. L., & Kupersmith, J. (1994) · International journal of cardiac imaging · doi:10.1007/bf01137903 · Cited by 3
“Two dietary and 3 pharmacologic primary prevention trials [21-25] have demonstrated a significant reduction in the incidence of CAD and related morbidity.”
BackgroundKrupski, W. C. (1994) · Annals of Vascular Surgery · doi:10.1007/bf02018180
Okada, S., Ichiki, K., Tanokuchi, S., & Ota, Z. (1993) · Journal of International Medical Research · doi:10.1177/030006059302100207
Dietary modulators of blood lipids in free living persons with high risk of coronary disease
Singh, R., Sharma, V., & Gupta, R. (1992) · doi:10.1080/00207239208710763
Cholesterol and screening of asymptomatic adults.
Muldoon, M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-384
Evaluation and Treatment of Hypercholesterolemia
Talbert, R. (1988) · Journal of Pharmacy Practice · doi:10.1177/089719008800100205
Coronary Heart Disease Prevention in Type II Primary Hyperlipoproteinaemia
Miller, G. (1985) · doi:10.1177/014107688507800320
“The inconclusive results of early clinical trials emphasized the practical problems involved in the test of the hypothesis and the inescapability of rigorous attention to study design (Rinzler 1968, Dayton et al. 1969).”
BackgroundZusammenhänge zwischen Serum-Lipoproteinstoffwechsel und biliärem Lipidstoffwechsel
Leiß, O., & Bergmann, K. (1983) · Klinische Wochenschrift · doi:10.1007/bf01487336
Fancourt, G. J., & Matts, S. G. F. (1982) · The British journal of clinical practice · doi:10.1111/j.1742-1241.1982.tb08395.x
Prevalence and awareness of hyperlipoproteinemia in physicians and their spouses
Wen, C. P., & Greenbaum David, S. (1976) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)05888-0
Langzeit-Therapie von Hyperlipoproteinämie der Typen IIa und IIb mit Etiroxat
Schwartzkopff, W., & Russ, E. (1975) · doi:10.1055/s-0028-1106301
Metadata
- Authors
- DAYTON, S., PEARCE, M. L., HASHIMOTO, S., DIXON, W. J., & TOMIYASU, U.
- Affiliations
- United States Department of Veterans Affairs (US)
- Venue
- Circulation
- Published
- 1969-07
- Volume
- 40
- Issue
- 1s2
- Pages
- 1237-42
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1991289303
- Cited by
- 595
- References
- 0
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 9 · 2023: 4 · 2022: 2 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 11 · 2017: 9 · 2016: 7 · 2015: 9 · 2014: 3 · 2013: 6 · 2012: 8
- FWCI
- 15.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- dietary fat, serum cholesterol, atherosclerosis, coronary artery disease, linoleic acid, dietary cholesterol, dietary adherence, dietary fat saturation, adipose tissue fatty acid composition, veterans, dietary intervention, cholesterol-lowering diet
- MeSH terms
- Aged, Cerebrovascular Disorders, Cholesterol, Clinical Trials as Topic, Coronary Disease, Dietary Fats, Fats, Unsaturated, Humans, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
